Vaginal Dryness
Reduced moisture is one of the most recognized GSM symptoms.
At Surrey Women’s Clinic, we provide private, personalized care for women experiencing the vaginal, vulvar and urinary symptoms associated with genitourinary syndrome of menopause.
Genitourinary syndrome of menopause—GSM—is a group of vaginal, vulvar and urinary symptoms associated with lower estrogen and other hormonal changes around menopause. It is common, often under-discussed and highly relevant to quality of life.
The Menopause Society describes GSM as bothersome vaginal, vulvar and urinary symptoms associated with menopause. Common symptoms include dryness, burning, irritation, painful intercourse, urinary urgency and recurrent urinary tract infections.
Reduced moisture is one of the most recognized GSM symptoms.
Vulvar or vaginal tissue may feel irritated, sensitive or uncomfortable.
Dryer, thinner and less elastic tissue can contribute to painful penetration.
Some women experience a stronger or more frequent need to urinate.
Postmenopausal changes can contribute to recurrent urinary tract infections in some women.
Fragile tissue may be more easily irritated, though bleeding still requires proper evaluation.
Estrogen receptors are present throughout vulvovaginal and lower urinary tissues. With lower estrogen, tissue can become thinner, drier, less elastic and more fragile, while changes in the genitourinary environment can contribute to urinary symptoms.
The term GSM replaced narrower terms such as vaginal atrophy because the condition affects more than the vagina. It recognizes that vulvar, vaginal, sexual and urinary symptoms can be connected through the same hormonal and tissue changes.
The right plan depends on clinical assessment, health history, severity, goals and treatment suitability. These are possible pathways—not a promise that every option is appropriate for every patient.
Non-hormonal moisturizers and lubricants can improve dryness and friction-related discomfort for many women.
Local estrogen is an established treatment for GSM in appropriate patients and can improve vaginal tissue symptoms.
Systemic therapy may be relevant when GSM occurs alongside bothersome vasomotor or other menopause symptoms.
Learn More →Surrey Women’s Clinic may discuss technology-based options after assessing the patient’s specific GSM-related concerns and treatment suitability.
Learn More →You do not need to diagnose yourself or select a device before contacting the clinic. The consultation is where symptoms, history and goals are reviewed so the appropriate next step can be determined.
Describe the symptoms, timing, triggers, life stage and how the concern affects your day-to-day life.
Dr. Maria Bleszynski can determine likely contributing factors and whether further evaluation is needed.
If treatment is appropriate, the clinic can discuss evidence-based and private wellness options suited to your individual situation.
Detailed answers make the page more useful for patients, search engines and Surrey Women’s Clinic’s future AI knowledge base.
Genitourinary syndrome of menopause.
No. It can include vulvar and vaginal dryness, burning, irritation, painful sex and urinary symptoms.
Yes. Urgency, frequency, recurrent urinary tract infections and other urinary concerns can be part of GSM.
Unlike some vasomotor symptoms, GSM often persists or progresses without treatment.
For appropriate patients, low-dose local estrogen is an established treatment for GSM.
Start with your concern rather than trying to choose the treatment yourself. A private consultation can help determine the cause, the appropriate care pathway and whether FormaV or another option belongs in your plan.
This page provides general educational information and does not replace medical advice, diagnosis or treatment. Symptoms can have multiple causes. Treatment suitability varies by individual and is determined after clinical assessment.
Need help finding the clinic? Call 604-583-8337 for directions or general assistance.